BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25317832)

  • 1. Polylysine-mediated translocation of the diphtheria toxin catalytic domain through the anthrax protective antigen pore.
    Sharma O; Collier RJ
    Biochemistry; 2014 Nov; 53(44):6934-40. PubMed ID: 25317832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen.
    Blanke SR; Milne JC; Benson EL; Collier RJ
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8437-42. PubMed ID: 8710889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus.
    Milne JC; Blanke SR; Hanna PC; Collier RJ
    Mol Microbiol; 1995 Feb; 15(4):661-6. PubMed ID: 7783638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen.
    Dmochewitz L; Lillich M; Kaiser E; Jennings LD; Lang AE; Buchner J; Fischer G; Aktories K; Collier RJ; Barth H
    Cell Microbiol; 2011 Mar; 13(3):359-73. PubMed ID: 20946244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel.
    Zhang S; Finkelstein A; Collier RJ
    Proc Natl Acad Sci U S A; 2004 Nov; 101(48):16756-61. PubMed ID: 15548616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
    Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
    Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing the receptor specificity of anthrax toxin.
    Mechaly A; McCluskey AJ; Collier RJ
    mBio; 2012; 3(3):. PubMed ID: 22550037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.
    Jennings-Antipov LD; Song L; Collier RJ
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1868-73. PubMed ID: 21262847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dynamin inactivation on pathways of anthrax toxin uptake.
    Boll W; Ehrlich M; Collier RJ; Kirchhausen T
    Eur J Cell Biol; 2004 Jul; 83(6):281-8. PubMed ID: 15511085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.
    Arora N; Leppla SH
    Infect Immun; 1994 Nov; 62(11):4955-61. PubMed ID: 7927776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
    Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
    ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
    Sun J; Collier RJ
    PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen.
    Janowiak BE; Finkelstein A; Collier RJ
    Protein Sci; 2009 Feb; 18(2):348-58. PubMed ID: 19165720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins.
    Basilio D; Jennings-Antipov LD; Jakes KS; Finkelstein A
    J Gen Physiol; 2011 Apr; 137(4):343-56. PubMed ID: 21402886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
    Sun J; Lang AE; Aktories K; Collier RJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of N-terminal His6-Tags in binding and efficient translocation of polypeptides into cells using anthrax protective antigen (PA).
    Beitzinger C; Stefani C; Kronhardt A; Rolando M; Flatau G; Lemichez E; Benz R
    PLoS One; 2012; 7(10):e46964. PubMed ID: 23056543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
    Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
    Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of anthrax protective antigen into liposomal membranes: effects of a receptor.
    Sun J; Vernier G; Wigelsworth DJ; Collier RJ
    J Biol Chem; 2007 Jan; 282(2):1059-65. PubMed ID: 17107945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that histidine protonation of receptor-bound anthrax protective antigen is a trigger for pore formation.
    Wimalasena DS; Janowiak BE; Lovell S; Miyagi M; Sun J; Zhou H; Hajduch J; Pooput C; Kirk KL; Battaile KP; Bann JG
    Biochemistry; 2010 Aug; 49(33):6973-83. PubMed ID: 20672855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.